PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 121 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $49,000 | +145.0% | 5,315 | +231.4% | 0.00% | -60.0% |
| Q2 2019 | $20,000 | +900.0% | 1,604 | +4235.1% | 0.01% | +400.0% |
| Q2 2018 | $2,000 | -33.3% | 37 | -24.5% | 0.00% | -50.0% |
| Q1 2018 | $3,000 | -25.0% | 49 | +22.5% | 0.00% | -33.3% |
| Q4 2017 | $4,000 | 0.0% | 40 | -66.4% | 0.00% | -25.0% |
| Q4 2016 | $4,000 | -84.6% | 119 | -86.8% | 0.00% | -92.2% |
| Q1 2016 | $26,000 | – | 900 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |